Osiris Therapeutics Inc.

MD · United States · Reporting entity ID 100000136556

Total reported 2019–2025

$1.11M

#1,266 of 2,960 reporting companies — 0% of all reported industry payments

$697K in general payments across 5,405 records, plus $413K in research funding across 29 records.

How it breaks down

General payments $696,850

Research funding $413,276

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.